| 2016 |
Kafui Patrick Akakpo |
Prevalence, types, and distribution of hr-HPV in cervical cancer patients in Ghana |
| 2016 |
Brooke Howitt |
Neuroendocrine carcinomas of the endometrium |
| 2017 |
Carlos Parra-Herran |
Genomic alterations in cervical adenocarcinoma |
| 2017 |
Bojana Djordjevic |
Cost analysis of germline vs tumor testing for BRCA mutations |
| 2018 |
Tjalling Bosse |
Relapsed disease in vulvar carcinomas |
| 2018 |
Kyle Strickland |
Nuclear B-catenin and squamous morules in EIN |
| 2019 |
Jennifer Bennett |
5hmC immunohistochemistry in FH-deficient leiomyomas |
| 2019 |
Sylvie Umuganwa |
Travel award to study abroad with an ISGyP mentor |
| 2019 |
Zewditu Chanyalew |
Travel award to study abroad with an ISGyP mentor |
| 2020 |
Nairi Tchrakian |
Genotype-phenotype correlation of Sertoli-Leydig cell tumors |
| 2020 |
Voskehat Mkrtumyan |
Placental infections in patients with preeclampsia |
| 2021 |
Basile Tessier Cloutier |
Longitudinal clonality between endometrial biopsies and endometrial cancers |
| 2021 |
Jonathan Wawire |
Endometrial carcinoma in Kenya: histologic subtypes and outcomes |
| 2021 |
Rawda Elshennawy |
The role of the UbcH-10 proto-oncogene in ovarian high grade serous carcinoma |
| 2022 |
Lynn Hoang |
Clarifying the clinical behavior of HPV-independent TP53 wild-type vulvar intraepithelial neoplasia |
| 2023 |
Felix Kommoss |
Advancing Accessible Molecular Testing in Gynecological Pathology: Nanopore-based Detection of Structural Variants in Uterine Mesenchymal Neoplasms |
| 2023 |
Aleksandra Asaturova |
ArlStOtel: Artificial intelligence-based system for serous ovarian cancer subtyping |